UTHR - United Therapeutics to buy Miromatrix Medical for $3.25 per share
2023-10-30 06:33:26 ET
More on United Therapeutics
- United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat
- United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision
- United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth More Than Justified
- Liquidia gains as court sets December date for hearing in patent dispute
For further details see:
United Therapeutics to buy Miromatrix Medical for $3.25 per share